KR20160079784A - 면역글로불린 분자 시료를 분석하는 방법 - Google Patents

면역글로불린 분자 시료를 분석하는 방법 Download PDF

Info

Publication number
KR20160079784A
KR20160079784A KR1020167010252A KR20167010252A KR20160079784A KR 20160079784 A KR20160079784 A KR 20160079784A KR 1020167010252 A KR1020167010252 A KR 1020167010252A KR 20167010252 A KR20167010252 A KR 20167010252A KR 20160079784 A KR20160079784 A KR 20160079784A
Authority
KR
South Korea
Prior art keywords
polypeptide
gly
ser
lys
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020167010252A
Other languages
English (en)
Korean (ko)
Inventor
프레드릭 올슨
마리아 노르드그렌
말린 메자레
사라 프레드릭슨
Original Assignee
게노비스 에이비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 게노비스 에이비 filed Critical 게노비스 에이비
Publication of KR20160079784A publication Critical patent/KR20160079784A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • G01N33/6857Antibody fragments
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472Cysteine endopeptidases (3.4.22)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52Constant or Fc region; Isotype
    • C07K2317/53Hinge
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22Cysteine endopeptidases (3.4.22)
    • C12Y304/2201Streptopain (3.4.22.10)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96402Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from non-mammals
    • G01N2333/96405Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from non-mammals in general
    • G01N2333/96408Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from non-mammals in general with EC number
    • G01N2333/96413Cysteine endopeptidases (3.4.22)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00Chemical aspects of mass spectrometric analysis of biological material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020167010252A 2013-09-20 2014-09-18 면역글로불린 분자 시료를 분석하는 방법 Withdrawn KR20160079784A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1316744.0A GB201316744D0 (en) 2013-09-20 2013-09-20 Method
GB1316744.0 2013-09-20
PCT/EP2014/069920 WO2015040125A1 (en) 2013-09-20 2014-09-18 A method for analysing a sample of immunoglobulin molecules

Publications (1)

Publication Number Publication Date
KR20160079784A true KR20160079784A (ko) 2016-07-06

Family

ID=49553168

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167010252A Withdrawn KR20160079784A (ko) 2013-09-20 2014-09-18 면역글로불린 분자 시료를 분석하는 방법

Country Status (9)

Country Link
US (1) US20160231329A1 (OSRAM)
EP (1) EP3047280A1 (OSRAM)
JP (1) JP2016531546A (OSRAM)
KR (1) KR20160079784A (OSRAM)
AU (1) AU2014323081A1 (OSRAM)
CA (1) CA2923704A1 (OSRAM)
GB (1) GB201316744D0 (OSRAM)
SG (1) SG11201602138VA (OSRAM)
WO (1) WO2015040125A1 (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1686302A (en) * 2000-12-21 2002-07-01 Shire Biochem Inc Streptococcus pyogenes antigens and corresponding dna fragments
CA2944767C (en) 2014-04-04 2022-07-12 Mayo Foundation For Medical Education And Research Isotyping immunoglobulins using accurate molecular mass
GB201502306D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502305D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
US11209439B2 (en) 2015-09-24 2021-12-28 Mayo Foundation For Medical Education And Research Identification of immunoglobulin free light chains by mass spectrometry
JP6788010B2 (ja) 2015-12-09 2020-11-18 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft インビボ相互作用様式を決定するための方法
CN108369232B (zh) 2015-12-09 2022-05-31 豪夫迈·罗氏有限公司 人IgG1结合多聚抗原的直接亲和力测量
JP7123801B2 (ja) * 2016-02-04 2022-08-23 ジェノビス エービー 新しい連鎖球菌プロテアーゼ
US20170370906A1 (en) * 2016-05-27 2017-12-28 Genentech, Inc. Bioanalytical analysis of site-specific antibody drug conjugates
US10955420B2 (en) 2016-09-07 2021-03-23 Mayo Foundation For Medical Education And Research Identification and monitoring of cleaved immunoglobulins by molecular mass
WO2018093868A1 (en) * 2016-11-16 2018-05-24 University Of Florida Research Foundation, Inc. Immunoglobulin proteases, compositions, and uses thereof
CN111183221B (zh) 2017-05-26 2024-04-09 杰诺维斯公司 用于o-糖蛋白的蛋白酶和结合多肽
WO2019055632A1 (en) 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF IMMUNOGLOBULIN CHAINS J
EP3681528B1 (en) 2017-09-13 2025-07-23 Mayo Foundation for Medical Education and Research Identification and monitoring of apoptosis inhibitor of macrophage
EP4079848A1 (en) * 2021-04-22 2022-10-26 Genovis Ab Immunoglobulin cleaving enzyme

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965709A (en) * 1991-08-14 1999-10-12 Genentech, Inc. IgE antagonists
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
CA2843158A1 (en) * 2011-08-26 2013-03-07 Merrimack Pharmaceuticals, Inc. Tandem fc bispecific antibodies

Also Published As

Publication number Publication date
WO2015040125A1 (en) 2015-03-26
SG11201602138VA (en) 2016-04-28
EP3047280A1 (en) 2016-07-27
JP2016531546A (ja) 2016-10-13
CA2923704A1 (en) 2015-03-26
US20160231329A1 (en) 2016-08-11
GB201316744D0 (en) 2013-11-06
AU2014323081A1 (en) 2016-03-31

Similar Documents

Publication Publication Date Title
KR20160079784A (ko) 면역글로불린 분자 시료를 분석하는 방법
Yan et al. Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain
Leblanc et al. Charge variants characterization of a monoclonal antibody by ion exchange chromatography coupled on-line to native mass spectrometry: Case study after a long-term storage at+ 5 C
CN102308216B (zh) 免疫球蛋白糖基化模式分析
Harris Heterogeneity of Recombinant Antibodies: linking Structureto Function
US10281473B2 (en) Compositions and methods for analysis of protein sequences and post-translational modifications
CA3050009A1 (en) Idiotypic antibodies against anti-pd-l1 antibodies and uses thereof
US20220276260A1 (en) Glucuronylation as a new acidic post-translational modification on therapeutic monoclonal antibodies
US20240190951A1 (en) Anti-tslp antibody compositions and uses thereof
Pham et al. De novo proteomic sequencing of a monoclonal antibody raised against OX40 ligand
Zhang et al. Characterization of asparagine deamidation and aspartate isomerization in recombinant human interleukin-11
US20170242032A1 (en) Method for analysing aggregates in antibody samples
US20220177582A1 (en) Non-consensus glycosylation of bispecific antibodies
Rak et al. Spontaneous proteolytic processing of human recombinant anti-mullerian hormone: structural and functional differences of the molecular forms
KR20170071849A (ko) Lc-ms를 이용하는 항체 약물의 혈액 내 정량방법
US20160252521A1 (en) Method for determining high-mannose glycans
Johnson et al. Monitoring manufacturing process yields, purity and stability of structural variants of PEGylated staphylokinase mutant SY161 by quantitative reverse‐phase chromatography
JP7602715B2 (ja) 抗体分析方法
Ruppen et al. Characterization of mAb size heterogeneity originating from a cysteine to tyrosine substitution using denaturing and native LC-MS
KR20230066025A (ko) 수소 교환 질량 분석법을 사용하는 결합 부위의 식별 방법
BALLAND BOXU YAN, SEAN STEEN, DAVID HAMBLY, JOHN VALLIERE-DOUGLASS, TIM VANDEN BOS, 2 SCOTT SMALLWOOD, 3 ZAC YATES, THOMAS ARROLL, 3 YIHONG HAN, HIMANSHU GADGIL, RAMIL F. LATYPOV, ALISON WALLACE, AICHING LIM, 2 GERD R. KLEEMANN, WEICHUN WANG

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20160419

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid